COMPASS predicts immunotherapy outcomes across cancers and treatments

COMPASS is a pan-cancer foundation model that predicts immunotherapy response from bulk tumor transcriptomes, validated across multiple cancer types and treatments. The model generalizes across different cancer indications and immunotherapeutic agents.